Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote USD

Teva Pharmaceutical Industries Limited (0LER.IL)

14.25
-0.10
(-0.70%)
At close: April 24 at 7:11:26 PM GMT+1

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 3.88B
Earnings --

Q3'22

Q4'22

Q1'23

Q2'23

0
1B
2B
3B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

8.00 Low
10.22 Average
14.25 Current
13.00

Earnings Estimate

Currency in USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
No. of Analysts 1051312
Avg. Estimate 0.710.572.512.56
Low Estimate 0.660.492.032.44
High Estimate 0.780.632.62.68
Year Ago EPS 0.770.552.582.51

Revenue Estimate

Currency in USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
No. of Analysts 941110
Avg. Estimate 4.02B3.68B15.41B15.52B
Low Estimate 3.95B3.57B15.09B14.92B
High Estimate 4.12B3.83B16.73B15.92B
Year Ago Sales 4.1B--15.88B15.41B
Sales Growth (year/est) -1.90%---2.90%0.70%

Earnings History

Currency in USD 12/31/2021 3/31/2022 6/30/2022 9/30/2022
EPS Est. 0.730.560.560.62
EPS Actual 0.770.550.680.59
Difference 0.04-0.010.12-0.03
Surprise % 5.50%-1.80%21.40%-4.80%

EPS Trend

Currency in USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
Current Estimate 0.710.572.512.56
7 Days Ago 0.70.572.512.55
30 Days Ago 0.710.562.52.55
60 Days Ago 0.730.552.442.58
90 Days Ago 0.730.552.442.58

EPS Revisions

Currency in USD Current Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
Up Last 7 Days 1--11
Up Last 30 Days 1111
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
0LER.IL -7.80%3.60%-2.70%2.00%
S&P 500 6.94%4.52%8.32%14.18%

Upgrades & Downgrades

Maintains B of A Securities: Buy to Buy 3/6/2025
Maintains UBS: Buy to Buy 1/30/2025
Maintains Barclays: Overweight to Overweight 1/30/2025
Maintains UBS: Buy to Buy 1/23/2025
Maintains Piper Sandler: Overweight to Overweight 1/17/2025
Maintains Barclays: Overweight to Overweight 12/18/2024

Related Tickers